EXHIBIT 11.1
ECLIPSE SURGICAL TECHNOLOGIES, INC.
STATEMENT REGARDING COMPUTATION OF NET LOSS PER SHARE
(in thousands, except per share amounts)
(unaudited)
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
--------------- -------------
1997 1996 1997 1996
---- ---- ---- ----
Weighted average common shares outstanding for the
period ............................................. 16,441 15,775 16,303 12,690
Common equivalent shares pursuant to Staff
Accounting Bulletin No. 83.......................... - - - 1,516
-------- -------- --------- --------
Shares used in per share calculations................. 16,441 15,775 16,303 14,206
-------- -------- --------- --------
-------- -------- --------- --------
Net loss.............................................. $(4,516) $ (674) $(13,015) $(1,328)
-------- -------- --------- --------
-------- -------- --------- --------
Net loss per share.................................... $ (0.27) $ (0.04) $ (0.80) $ (0.09)
-------- -------- --------- --------
-------- -------- --------- --------
All share numbers reflect the Company's three-for-one stock split.
There is no difference between primary and fully diluted earnings per
share for each period presented.